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GENESIS OF THE SWEAT:PLASMA UREA CONCENTRATION GRADIENT 
R OBERT S. GORDON, JR. , M . D . , RONALD H. T HOMPSON, PH .D .. DEL THRASHER , ANO JA MES W . BENSON. JR . , M.D . 
Section on Physiology and Clinical Nutrition , Nationoi Institute of Arthritis, Metabolism. and Digestive 
Diseases. National Institutes of Hea lth. Bethesda , Maryland. U.S.A. 
Experiments with uC·labeled urea ir. human volunteers show th at urea is sequestered in 
the epidermis. where it turns over more slowly than in general body water . Sequestered urea, 
presumed to be concentrated through insensible evaporation of water, is the source of the 
excess urea found in sweat. Physiologic and cl inical implications of the exist.ence of this urea 
pool are discussed. 
It has been known for years that human eccrine 
sweat contains urea at a concentration highe r than 
that of blood, but a physiologically satisfactory 
explanation for the genesis of this concentrat ion 
gradient has not been available. Schwartz, Thay-
sen, and Dole [I [ suggested that passive reabsorp-
tion of water in excess of urea in the sweat duct 
might produce the gradient. They support ed their 
hypothesis with experiments. but the studies that 
they were able to carry out at that time produced 
only indirect evidence which was consisten t with. 
but did not prove, the hypothesis. 
More recently, using urea labeled with 14C. 
Brusilow (2 ) obtained results that make the above 
hypothesis untenable. Collecting sweat 2 to 3 hr 
after giving labeled urea to four volunt.eers. he 
found mean sweat:plasma concentration ratios of 
1.43 fo r total urea determined chemically, and only 
1.08 for "C urea. Whereas the reabsorpt ion hy-
pothe is requ ires that these ratios he the same. 
they were significantly different even with th is 
limited number of subjects. Brusilow postulated 
that the excess urea found in sweat must he 
derived from a non-plasma sou rce, and suggested 
"synthe is of urea by some segment of the sweat 
gland, or a pool of urea in the skin (perhaps the 
corn ified epidermis) which is immiscible with the 
ci rculating labeled urea, but which may be par-
tially miscible with the sweat.. .. 
The experiments we report here were undertaken 
to dist inguish between these two possibilities. and 
to attempt to learn more ahout the nature and 
locat ion of the non-plasma source of sweat urea . 
MATERIALS A:srO METHODS 
The yolunteers who served as subjects for these experi-
ments were in· patients at the Clinical Center of the 
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National Institutes of Health . Two had been admitted for 
surgical treat ment of malignant disease. whereas the 
remainder were healthy college students admitted solely 
for research. Each was informed of the nature and 
purpose of the research. and each cOI~ sented freely to 
part icipate. 
L'C Urea was purchased from the New England Nu-
clear Corporation. and was prepared for clinical use by 
the Radiopha rmaceutical Section of the NI H Clinica l 
Cent er Pharmacy Department. The substance was reo 
chromatographed to show that no labeled impurities 
could be detected. and was then made up in 8. sterile. py-
rogen·free. injectable solu t ion. and tested fo r safety prior 
to use. 
Whole-body !'weat was collected from the normal 
subjects and concent rated for analysis by a procedure 
which has be-en published in detail previously 13 J. The 
volunteer was allowed to sweat for a period of 2 hr in a 
hot. dry atmosphere. while lying in a nylon mesh ham· 
mock suspended on a scale. At the end of this period. 
sweat solutes were eluted by washing down the subjec t 
with disti lled water. which was concentrated under 
vacuum for analysis . Weight loss during the period of 
heat exposure was taken a!' an est imate of original sweat 
volume. A urine sample corresponding: with the pe riod of 
sweating was obtained by having the subject void volun· 
ta rily at the beginning and end of the period. Samples of 
sweat and urine were analyzed for total urea content by 
the method of An nino 141. 
In the twO pat ients undergoing amputation of an 
extremity for malignant disease. skin and muscle samples 
were obtained within 30 min. using sharp dissection with 
scalpel and Brown de rmatome. 
S weat and urine samples were counted in a Packard 
Tri-Carb model 3320 liquid scinti llation s pectrometer. 
using Bray's solution. Correction for va riable quenching. 
where present . was done with the automatic exte rnal 
standard : quenching was less than 15 % in all but a few 
scattered samples. Tissue samples were prepared for 
liquid scintillation cou nting by means of the Packard 
model 30il sample oxidizer. and counted in the same 
spectrometer. No variable quenching was encountered 
with the oxidized material s. In even the least -radioactive 
samples. enough counts were collected t.o reduce ant.ici · 
pated statisti cal counting errors to below 5%. 
RESULTS 
As a prelimina ry study. recovery in the bath of 
known amounts of 14C·urea applied to the skin of 
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normal subjects was checked. As in our earlier 
study of lactate [31, we found recovery after 5 min 
to be 94 ± 9.3% (mean ± SEM), but only 71 ± 2% 
after 3 hr. Loss of up to 30% of the urea from sweat, 
however. was felt to be acceptable, since the 
subsequen t studies were to depend on specific 
activity, not total quantity, of sweat urea. 
Eight normal volunteers each received 5 to 6 ~Ci 
of labeled urea orally or intravenously and pro-
vided satisfactory sweat and urine samples on the 
day of administration and again on the 1st. 2nd , 
and 3rd subsequent days. The period of sweat and 
urine collection on day zero began 90 min after the 
labeled urea was given. Urea specific activity was 
taken as the ratio of counts per min per rol of 
sample to mg urea per ml of the same sample. The 
figures obtained are presented graphically in the 
Figure, where it may be seen that while urine urea 
(and , hence, presumably blood urea) was more 
radioactive than sweat urea on the 1st day , the 
relationship changed on subsequent days, and 
sweat urea became more highly labeled than urine 
urea . The mean sweat: urine ratios of specific 
activity are shown in Table 1. 
In order to justify the assumpt.ion , implicit in the 
above calculation, that all He counts in sweat or 
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FIG . Mean values for specific activity of I·e_urea in 
urine and sweat of 8 normal subjects . Data from each 
subject were first normalized to make urine specific 
activity on day 0 equal 1000. 
TABLE 1. Sweat:urine specific activity ratios in normal 
subjec ts after administration of I· e urea 
p Value (Student's 
Standard t-test) for contrast of 
Day Rati o error of observed ratio with : the mean 
In ~ 8) Unity Previous day 's ratio 
0 0 .76 0.04 < .001 
l.li 0.Q7 < .025 < .001 
2 1.78 O.li < .001 < .005 
3 3.54 0.77 < .005 <.025 
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urine represented urea, samples obtained on the 
1st day after injection were incubated with urease 
(Fisher Chemical CO.) in bicarbonate buffer, pH B, 
at 37°C for 30 min . The solution was then acidified 
and heated to expel carbon dioxide. In only one 
individual'S sweat was there clearly detectable 
radioactivity remaining, and this was less than 5% 
of the radioactivity present prior to urease treat-
ment. Sweat samples from days 2 and 3 contained 
so few counts that the above experiment could not 
be carried out satisfactorily. 
Two patients scheduled for amputation of an 
extremity for malignant disease each received 100 
~Ci of labeled urea 2 days prior to operation. As 
soon as possible after the amputated limb had 
been freed, 3 or more specimens of epidermis, and 3 
or more of underlying muscle were obtained. The 
surface of the skin was wiped several times with a 
moist towel before the dermatome was applied , in 
order to be sure that there would be no urea on the 
surface derived from sweat that might have been 
secreted during or just preceding the operation. 
Wet and dry weights for these tissue samples were 
recorded , and the total I'e radioactivity of each 
was determined aft.er combustion to carbon diox-
ide. A separate skin sample obtained at the same 
time was examined histopathologically; this dem-
onstrated that the sample corresponded very 
closely with epidermis, and included only minimal 
amounts of subepidermal tissue. Differences in 
precen t dry weight between skin and muscle sam-
ples were not significant; t herefore, we have tabu· 
lated the primary data <radioactivity per gm fresh, 
wet tissue) in Table 11 . It may be seen that at this 
time, the 2nd day after administration of the He 
urea, considerably more of the label waS stored in 
epidermis than in muscle . This result would not 
have been anticipated if the ability of urea to 
diffuse rapidly through all body tissues. and to 
accumulate in proportion to their water content 
[51, a ppl ied equally to the epidermis . 
O1SCUSSIO~ 
The subjects for this study were either healthy 
volunteers. or patients undergoing surgery in the 
hope of a cure for malignant disease. Radiation 
safety considerations, therefore, dictated that the 
dose of isotopic urea be kept as low as possible. 
consistent with our being able to obtain interpreta-
ble data. It is , therefore, necessary to examine the 
possibility that. although urea is a metabolic end 
product primarily excreted by man without being 
reutilized . some of the residual 14C counts might 
TABLE 11. He in skin and muscle two da.vs after 
administration of I'e urea 
Cpm /v;m tissue p \' alue 
Patient (mean ± SEM l (Student 's 
Skin MusclE" c-test ) 
B.B. 251 ± 12.6 124 ± 5.6 <.001 
G.Mcl. 288 ::1: 22 20 ± 0.8 < .001 
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have represented persistence of isotope in sub-
stances that turn over more slowly than does urea. 
The first argument against this poss ibility is 
that the radioactivity present in the sweat and 
urine of the normal volunteers one day after 
administration of the dose could be discharged by 
treatment with urease, proving that it was still 
present as urea . By the next day. however. radioac-
tivity levels were so low that. even if 10% of the 14C 
had been urease-resistant. we would have encoun-
tered large experi mental errors in distinguishing it 
from background . Proof that radioactivity present 
on days 2 and 3 was actually urea is not essential to 
ou r thesis, however, since the change in sweat: 
urine specific activity ratio between days 0 and 1 
was already highly sign ificant statistically (p < 
0.001 by Student 's t-test). and the mean sweat: 
urine specific activity ratio was significantly above 
unity on day 1 (p < 0.025). 
The second argument is based on current knowl-
edge of the fate of urea in mammalian metabolism 
[6-9 I. Of a dose of labeled urea, most is excreted 
unchanged in the urine . but some 15 to 30% may be 
hydrolyzed to ammonia and carbon dioxide by 
intestinal bacteria . Labeled carhon dioxide result -
ing from the hydrolysis of "C urea is in turn dis· 
posed of primarily in the expired ai r. A small frac-
tion of any dose of labeled CO z• however. is rein-
corporated into liver argin ine. and thence into 
newly synthesized urea and into protei ns syn-
thesized by the liver. The fraction of a dose of la-
beled CO 2 ut ili zed for protei n synthesis is very 
small. and does not exceed 0.02% in man [ to I. It 
is not known whether any fixation of CO? into pro· 
teins and other macromolecules occurs in tissues 
other than liver, where it appears to be a by-prod-
uct of the production of urea via the Krebs cycle. 
Multiplying 30% by O.(r2<k yields 0.006% as a rea-
sonable upper limit fo r the fraction of He admin-
istered as urea that mi ght eventually be found in 
proteins distributed t hrough the whole body of the 
subject. and this quantity is much too small to 
account for the observed persistence of the I·e 
label in sweat and epidermal tissue. We must, 
therefore, attribute the late radioactivity in these 
specimens to the existence in the epidermis of a 
pool of urea that is not in rapid isotopic equilib· 
riurn with blood plas ma and other body water. 
The second hypothesis advanced by Brusi low in 
1967. namely that. epidermis contains a pool of 
urea immiscible with circulating urea but partially 
miscible with sweat. appears to fit our observations 
well if it is slightly modified . It would appear t hat 
this epidermal pool receives its input from blood 
urea. but does so only slowly . Thus. the u rea 
contri buted to sweat by this postulated pool is less 
radioactive than is blood or urine urea an hour or 
two after a tracer dose of labeled urea is given. 
resulting in a reduction in the specific activity of 
sweat urea below what it would have been had t he 
sweat urea all been derived directly from blood. On 
later days, however. persistence of labeled urea in 
the skin while the rapidly renewed body urea pool 
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loses radioactivity, results in the format ion of 
sweat containing urea with a specific activity 
higher t han t hat of blood . Neither the hypothesis 
of Schwartz et al III, which would require t hat 
sweat:urine specific activity ratios always be un ity. 
nor the first hypothesis of Brusilow 12J, which 
would require that sweat urea always be diluted 
with unlabeled urea synthesi zed in the sweat 
gland , can be made to fit the resul ts of our present 
study . 
If an epidermal urea pool which turns over slowly 
explains our observations on specific activity of 
sweat urea, how does it account for the concentra-
tion gradient? Brusilow showed that sweat con-
tained labeled urea in a concentration equal to that 
occurring in blood plasma at the same time; the 
urea derived from the epidermal pool was, in 
effect. added to that secreted by the sweat gland. It 
was as though sweat containing labeled urea in 
isotopic and chemical equil ibrium with blood had 
passed over a solid urea phase. dissolvin~ extra 
urea . before appearing at the skin surface . We 
suggest that t his analogy is vi rt ually the case, and 
that the excess urea in the epidermis is that which 
accompanied the water giving rise to the well· 
known t ransepiderm al water loss III I. It does not 
matter whether this wat.er enters the epidermis by 
simple diffusion from below or is provided to the 
outer cornified layers by otherwise im perceptible 
sweating . Eit.her mechanism would provide an 
input of wa ter containing urea at physiol ogic 
concentrations. and in eit her case the urea would 
remain behind and become concentrated as the 
water evaporates. Thus, although we have not 
measured its concentration directly. we can postu· 
late that since epidermal urea is not free to diffuse 
back into and equilibrate with the general body 
pool , the chemical concentration of urea in epider-
mis must exceed that in body wat.er because of the 
evaporation of its original solvent. 
If t he urea concentrated in superficial epidermal 
layers arr ived there along with the water which is 
subsequently lost as insensible evaporation. the 
input rate can be estimated on the basis of the 
known magnitude of transepidermal water loss 
(about 0.5 liter per day in an average man 111 n. The 
rate of input can hardly exceed the product of this 
volume and the mean blood urea concentra1 ion. 
which in a normal subject would be on the order of 
75 mg urea nitrogen, or slightly more than 150 mg 
of urea , per day. Loss of urea from the pool might 
occur by back -diffusion into the blood plasma, and 
must surely occur with manifest sweating, and 
with desquamation and replacement of cornified 
epiderm al cells. Beginning with the esti mate of 
about 10 days for the turnover time of cornified 
epidermis !ll]. it seems reasonable to assume that 
the turnover time for the epidermal urea pool 
might be about I week, and that its content. in a 
norm al subject, might total about I gm of urea. It 
should be noted that all these estimates would 
have to be revised upward in proportion to in · 
creases in blood urea concentrations in uremic 
April 1976 
subjects. (This linear proportionality would explain 
the fac t that Schwartz et al til found the same 
sweat: plasma urea concentration ratios in uremia 
t hat they had obtained in norm al subjects.) 
If t he epidermal urea pool is finite in size. it 
follows that it must be possible under a ppropriate 
ci rcumstances to wash out enough of the stored 
urea to produce a fall in the sweat: plasma urea 
co ncentrat ion ratio. Komives. Robinson, and Rob-
erts [12] appear to have documented this wash-ou t 
phenomenon. Subject ing normal men to cond itions 
that resulted in high sweat rates over long periods, 
they observed progressive reduction of sweat : 
plasma urea concentrat ion ratios toward unity, 
and ultimately concluded t hat. sweat urea was 
derived di rectly by diffusion from blood urea 
without becoming concentrated in the sweat gland. 
The t ransport of substances d issolved in bl ood 
plasma to the outer layers of skin through diffus ion 
a nd /or sweating, and thei r subsequent concentra· 
tion there as a result of the evaporation of waier. 
may have consequences of clinical significance. 
Shah, Epstein. and Riegelman [13] have rel ated 
epidermal concentrations of griseofulvin to this 
process. Further attent ion to the use of systemi· 
cally administered. as opposed to topical. drugs for 
the treatment of skin conditions may be warranted 
if thei r molecular properties can be so chosen that 
they will be secreted in sweat. and deposited in , as 
well as on, t he epidermis. 
The aut-hors are indebted t.o the surgical and patho· 
logic staff. National Cancer Institut.e. fo r the opportun ity 
to S1 udy the two pat.ients unde rgoing amputations for 
malignant disease: 10 the Clinical Chemistry Service. 
NIH Clinical Center. for urea and other analvses: and to 
Mrs. Julie Murphy and Mr . Ted Watkins for technical 
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assistance. Dr. Mones Berman and Mrs. Marjory Weiss 
a re particularly to be thanked fo r providing assistance 
and advice in testing the conclusions derived in qualita-
t ive fo rm in this paper by formal mathemat.ical modeling 
techniques (results not yet published). 
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